Skip to main content

Table 1 Clinical and pathological features of reported sebaceous carcinoma of the breast

From: Sebaceous carcinoma of the breast: a case report

Authors (ref. no.) Year Age (years) Sex Side ER PgR AR HER2 Oil red O Sudan Black B CAM5.2 CK7 Ber-EP4 EMA MIB-1 Adipophilin pTNMa Prognosis
Prescott et al [9] 1992 74 F R      (+)   (+)    (+)    T2NxMx NA
Mazzella et al. [10] 1995 55 M L (+) (+)    (+)         T2N0Mx AWNED, 10 months
Tavassoli [11] 1999 46 F R (−) (+)          20%   T3N0Mx NA
Varga et al. [12] 2000 45 F R (+) (+)   (−)        16%   T2NxMx AWD, 132 months
Hisaoka et al. [13] 2006 71 F R (+) (+)    (+)      (+) 38%   T1cN1-2 Mx NA
Numoto et al. [14] 2007 49 F L (+) (+) (+) (−)    (+)    (+) 15%   T1cNxMx NA
Murakami et al. [15] 2009 50 F L (−) (−) (+) (+)    (+)    (+) 30% (+) T1cN1-2 Mx AWNED, 24 months
Ramljak et al. [16] 2010 85 F L (−) (−)   (−)        25%   T2NxMx NA
Švajdler et al. [17] 2015 65 F R (+) (+)   (−)       (+) 30%   T1cN1aM0 AWNED, 27 months
Švajdler et al. [17] 2015 61 F R (−) (−)   (+)       (+) 80%   T2N1aM1 DOD, 28 months
Švajdler et al. [17] 2015 66 F R (+) (+)   (+)        5%   T2N1aM1 AWD, 70 months
Švajdler et al. [17] 2015 25 F R (+) (+)   (−)       (+)    TxN0Mx AWNED, 75 months
Yamamoto et al. (current case) 80 F L (−) (−) (−) (−)   (+)   (+) (+) (+)   (+) T2N0M0 AWNED, 16 months
  1. Abbreviations: AR androgen receptor, AWD alive with disease, AWNED alive with no evidence of disease, Ber-EP4 EpCAM antibody, CAM5.2 anti-low molecular weight keratin, CK7 cytokeratin 7, DOD died of disease, EMA epithelial membrane antibody, ER estrogen receptor, F female, HER2 human epidermal growth factor receptor type 2, L left, M male, MIB-1 anti-human Ki-67 antigen, NA not available, PgR progesterone receptor, R right
  2. aAccording to International Union Against Cancer TNM Classification of Malignant Tumors (7th Edition)